IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle

Br J Pharmacol. 2003 Dec;140(7):1159-62. doi: 10.1038/sj.bjp.0705558. Epub 2003 Nov 3.

Abstract

Growing evidence suggests that interleukin (IL)-13, a Th2-type cytokine, plays a critical role in the development of bronchial hyper-responsiveness (BHR), an essential feature of asthma, although the underlying mechanisms remain unknown. In the present study, we investigated whether IL-13 directly affects airway smooth muscle (ASM) function. In murine tracheal rings, IL-13 (100 ng ml-1, 24 h) significantly increased both the carbachol- and KCl-induced maximal force generation without affecting ASM sensitivity. In cultured human ASM cells, IL-13 (50 ng ml-1, 24 h) also augmented cytosolic calcium levels to bradykinin, histamine and carbachol by 60, 35 and 26%, respectively. The present study demonstrates that IL-13 may promote BHR by directly modulating ASM contractility, an effect that may be due to enhanced G protein-coupled receptor (GPCR)-associated calcium signaling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bradykinin / pharmacology
  • Calcium / metabolism
  • Calcium Signaling / drug effects*
  • Carbachol / pharmacology
  • Cells, Cultured
  • Cytosol
  • Dose-Response Relationship, Drug
  • Histamine / pharmacology
  • Humans
  • Interleukin-13 / pharmacology*
  • Mice
  • Muscle Contraction / drug effects*
  • Muscle, Smooth / drug effects*
  • Potassium Chloride / pharmacology
  • Recombinant Proteins / pharmacology
  • Trachea / drug effects*

Substances

  • Interleukin-13
  • Recombinant Proteins
  • Potassium Chloride
  • Histamine
  • Carbachol
  • Bradykinin
  • Calcium